Form D · Other Health Care
North Texas Renal Management VIII, LLC
Dallas, TX · CIK 0001762504
Offering snapshot reported Aug 21, 2025 · SEC filing
- Reported sold
- $30K Offering amount: $204K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jun 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2025 | Initial | $30,000 | No comparison | 3 | SEC filing |
| Dec 21, 2018 | Initial | $512,550 | No comparison | 61 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-555502
Source: Form D, filed Aug 21, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Fuquay, Md | Director |
| Steven M Gieser, M.D. | Director, Executive |
| Alexander Liang, M.D. | Director |
| Joris M Schuller, Jr., M.D. | Director |
| Joris M. Schuller, Jr., M.D. | Director |
| Anupkumar Shetty, M.D. | Director, Executive |
| Geoffrey Walker, M.D. | Director, Executive |
| Venkata Yalamanchili, Md | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1505 Lbj Freeway Suite 700
Dallas, TX, 75234
Dallas, TX, 75234